Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Edwards Lifesciences Corp shares valued at $204,865 were sold by Chopra Daveen on Aug 25 ’25. At $81.95 per share, Chopra Daveen sold 2,500 shares. The insider’s holdings dropped to 30,996 shares worth approximately $2.33 million following the completion of this transaction.
Also, Chopra Daveen purchased 2,500 shares, netting a total of over 204,865 in proceeds.
Before that, Wood Larry L had sold 8,950 shares from its account. In a trade valued at $698,679, the Global President TAVR & Surg traded Edwards Lifesciences Corp shares for $78.06 each. Upon closing the transaction, the insider’s holdings decreased to 8,950 shares, worth approximately $15.56 million.
As published in a research note from Oppenheimer on October 08, 2025, Edwards Lifesciences Corp [EW] has been rated down from an Outperform to a Perform. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in early October. As of July 29, 2025, BTIG Research has increased its “Neutral” rating to a “Buy” for EW. Earlier on April 24, 2025, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for EW stock which previously was a “a Neutral”.
Analyzing EW Stock Performance
On last trading session, Edwards Lifesciences Corp [NYSE: EW] plunged -0.73% to $75.19. The stock’s lowest price that day was $74.72, but it reached a high of $75.84 in the same session. During the last five days, there has been a drop of approximately -1.90%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 16.50%. Shares of the company reached a 52-week high of $83.00 on 07/25/25 and a 52-week low of $65.94 on 04/09/25.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 74.65, which, if violated, would cause prices to drop to 74.10. In the upper region, resistance lies at 75.81. The next price resistance is at 76.42. RSI (Relative Strength Index) is 40.01 on the 14-day chart, showing neutral technical sentiment.
Is Edwards Lifesciences Corp subject to short interest?
Stocks of Edwards Lifesciences Corp saw a sharp steep in short interest on 2025-09-15 dropping by -0.88 million shares to 7.26 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 8.14 million shares. A decline of -12.09% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.86 of the overall float, the days-to-cover ratio (short ratio) decline to 1.86.
Which companies own the most shares of Edwards Lifesciences Corp (EW)?
In terms of Edwards Lifesciences Corp share price expectations, FactSet research, analysts set an average price target of 85 in the next 12 months, up nearly 12.23% from the previous closing price of $75.74. Analysts anticipate Edwards Lifesciences Corp stock to reach 88 by 2025, with the lowest price target being 75. In spite of this, 17 analysts ranked Edwards Lifesciences Corp stock as Buy at the end of 2025. On January 30, 2025, Stifel assigned a price target of “a Buy” to the stock and upgraded coverage with a $90.
